SCHEMBL13613632

SCHEMBL13613632

COc1ccccc1CNC(=O)Nc1cccc2c1CC(O)CC2

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
TRPV1 Q8NER1 11/20 0.50
OPRM1 P35372 1/20 0.50
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
HPGD P15428 2/20 0.47
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
ALOX15 P16050 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
MTNR1A P48039 2/20 0.47
MTNR1B P49286 2/20 0.47
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13613640 0.88 TRPV1 (0.49) TRPV1OPRM1KMT2AALDH1A1GAA
SCHEMBL13613607 0.86 TRPV1 (0.53) TRPV1OPRM1MEN1KMT2AALDH1A1
SCHEMBL2733684 0.85 HDAC1 (0.48) LMNASMN1; SMN2TRPV1OPRM1MEN1
SCHEMBL2734544 0.85 TRPV1 (0.48) LMNASMN1; SMN2TRPV1OPRM1GAA
SCHEMBL13613613 0.84 TRPV1 (0.57) SMN1; SMN2TRPV1OPRM1ALDH1A1
SCHEMBL13613610 0.84 TRPV1 (0.53) LMNATRPV1OPRM1KMT2AHPGD
SCHEMBL13613651 0.84 TRPV1 (0.53) TRPV1OPRM1
SCHEMBL13613641 0.84 TRPV1 (0.53) TRPV1OPRM1
SCHEMBL4339142 0.84 TRPV1 (0.48) LMNASMN1; SMN2TRPV1OPRM1KMT2A
SCHEMBL5111925 0.84 LMNA (0.51) LMNATRPV1KMT2AMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed